Search results
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 6 days agoVaccine manufacturers, including Pfizer, Moderna, and Novavax, have already been working on a JN.1...
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 4 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Venus Concept Stock Soars 127% Premarket After Regaining Nasdaq Compliance - Venus Concept...
Benzinga· 7 days agoVenus Concept Inc. VERO, a company specializing in medical aesthetic technology, saw its stock price...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 5 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via AOL· 7 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 4 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...